138 related articles for article (PubMed ID: 10565978)
1. Lubeluzole. JK 8792, R 87926, Prosynap.
Drugs R D; 1999 Jan; 1(1):29-31. PubMed ID: 10565978
[No Abstract] [Full Text] [Related]
2. BAY X 3702.
Drugs R D; 1999 Jan; 1(1):16-7. PubMed ID: 10565971
[No Abstract] [Full Text] [Related]
3. Gavestinel. GV 150526, GV 150526A.
Drugs R D; 1999 Jan; 1(1):23-4. PubMed ID: 10565975
[No Abstract] [Full Text] [Related]
4. Ziconotide. CI 1009, SNX 111.
Drugs R D; 1999 Jan; 1(1):46-8. PubMed ID: 10565986
[No Abstract] [Full Text] [Related]
5. BIII 277CL. BIII 277, BIII 281CL.
Drugs R D; 1999 Jan; 1(1):18-9. PubMed ID: 10565972
[No Abstract] [Full Text] [Related]
6. Lubeluzole treatment of acute ischemic stroke. The US and Canadian Lubeluzole Ischemic Stroke Study Group.
Grotta J
Stroke; 1997 Dec; 28(12):2338-46. PubMed ID: 9412611
[TBL] [Abstract][Full Text] [Related]
7. Multinational randomised controlled trial of lubeluzole in acute ischaemic stroke. European and Australian Lubeluzole Ischaemic Stroke Study Group.
Diener HC
Cerebrovasc Dis; 1998; 8(3):172-81. PubMed ID: 9619701
[TBL] [Abstract][Full Text] [Related]
8. ZD 9379.
Drugs R D; 1999 Jan; 1(1):44-5. PubMed ID: 10565985
[No Abstract] [Full Text] [Related]
9. Siagoside. GM1, Sygen.
Drugs R D; 1999 Jan; 1(1):36-7. PubMed ID: 10565981
[No Abstract] [Full Text] [Related]
10. Nitrous oxide modulator: lubeluzole.
Diener HC; Wessel TC
Curr Med Res Opin; 2002; 18 Suppl 2():s23-6. PubMed ID: 12365825
[TBL] [Abstract][Full Text] [Related]
11. OPC 14117.
Drugs R D; 1999 Jan; 1(1):34-5. PubMed ID: 10565980
[No Abstract] [Full Text] [Related]
12. Lubeluzole in acute ischemic stroke treatment: A double-blind study with an 8-hour inclusion window comparing a 10-mg daily dose of lubeluzole with placebo.
Diener HC; Cortens M; Ford G; Grotta J; Hacke W; Kaste M; Koudstaal PJ; Wessel T
Stroke; 2000 Nov; 31(11):2543-51. PubMed ID: 11062273
[TBL] [Abstract][Full Text] [Related]
13. Clomethiazole. Chlormethiazole, Zendra.
Drugs R D; 1999 Jan; 1(1):20-1. PubMed ID: 10565973
[No Abstract] [Full Text] [Related]
14. Combination Therapy Stroke Trial: recombinant tissue-type plasminogen activator with/without lubeluzole.
Grotta J;
Cerebrovasc Dis; 2001; 12(3):258-63. PubMed ID: 11641593
[TBL] [Abstract][Full Text] [Related]
15. Hu23F2G. 23F2G, LeukArrest.
Drugs R D; 1999 Jan; 1(1):25-6. PubMed ID: 10565976
[No Abstract] [Full Text] [Related]
16. Safety and pharmacokinetics of the neuroprotective drug lubeluzole in patients with ischemic stroke.
De Keyser J; Van de Velde V; Schellens RL; Hantson L; Tritsmans L; Gheuens J; Van Peer A; Woestenborghs R; Franke CL; van Gorp J
Clin Ther; 1997; 19(6):1340-51. PubMed ID: 9444444
[TBL] [Abstract][Full Text] [Related]
17. Lubeluzole for acute ischaemic stroke.
Gandolfo C; Sandercock P; Conti M
Cochrane Database Syst Rev; 2002; (1):CD001924. PubMed ID: 11869612
[TBL] [Abstract][Full Text] [Related]
18. Licostinel. ACEA 1021.
Drugs R D; 1999 Jan; 1(1):27-8. PubMed ID: 10565977
[No Abstract] [Full Text] [Related]
19. YM 900. YM 90K.
Drugs R D; 1999 Jan; 1(1):42-3. PubMed ID: 10565984
[No Abstract] [Full Text] [Related]
20. Combination therapy stroke trial. rt-PA +/- lubeluzole.
Grotta J
Ann N Y Acad Sci; 2001 Jun; 939():309-10. PubMed ID: 11462784
[No Abstract] [Full Text] [Related]
[Next] [New Search]
